Skip to main content
Jason Ehrlich, MD, Ophthalmology, South San Francisco, CA

Jason Ehrlich MD


Physician

Join to View Full Profile
  • 1 Dna Way Ms 454bSouth San Francisco, CA 94080

Dr. Ehrlich is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Ophthalmology, 2005 - 2008
  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterInternship, Transitional Year, 2004 - 2005
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2005 - 2026
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • SUBSPECIALTY NEWS: Port Drug Delivery in DME, Integrin Inhibitors, Treatment for XLRP, Eye Drops for DME, Gene Therapy, and More
    SUBSPECIALTY NEWS: Port Drug Delivery in DME, Integrin Inhibitors, Treatment for XLRP, Eye Drops for DME, Gene Therapy, and MoreMarch 1st, 2020
  • Kodiak Sciences Announces Additional Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and R...
    Kodiak Sciences Announces Additional Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and R...February 8th, 2020
  • SUBSPECIALTY NEWS: Stem-Cell Therapy for Geographic Atrophy, Artifacts in OCTA, European Opinion for Beovu, and More
    SUBSPECIALTY NEWS: Stem-Cell Therapy for Geographic Atrophy, Artifacts in OCTA, European Opinion for Beovu, and MoreFebruary 1st, 2020
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: